[18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers

Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers

(2021) Mica T. M. Clarke et al.   Alzheimers Research & Therapy

Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum

(2020) W Richard Bevan-Jones et al.   BRAIN

Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes

(2020) Adam S. Fleisher et al.   JAMA Neurology

Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies

(2019) Débora E. Peretti et al.   PLoS One

In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier

(2019) W. Richard Bevan-Jones et al.   Annals of Clinical and Translational Neurology

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes

(2019) Richard M. Tsai et al.   Alzheimers Research & Therapy

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

(2019) Henri J M M Mutsaerts et al.   BRAIN

Progressive tau accumulation in Alzheimer’s disease: two-year follow-up study

(2019) Hanna Cho et al.   JOURNAL OF NUCLEAR MEDICINE

Neuroinflammation in frontotemporal dementia

(2019) Fiona Bright et al.   Nature Reviews Neurology

Longitudinal (18F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation

(2019) Rhian S Convery et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Tau-positron emission tomography correlates with neuropathology findings

(2019) Val J. Lowe et al.   Alzheimers & Dementia

Predominant subcortical accumulation of 18 F-flortaucipir binding in behavioral variant frontotemporal dementia

(2018) Hanna Cho et al.   NEUROBIOLOGY OF AGING

In vivo18F-AV-1451 tau PET signal inMAPTmutation carriers varies by expected tau isoforms

(2018) David T. Jones et al.   NEUROLOGY

Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807

(2018) David T. Chien et al.   JOURNAL OF ALZHEIMERS DISEASE

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

(2018) Rosalinde E. R. Slot et al.   Alzheimers Research & Therapy

Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia

(2018) Lize C Jiskoot et al.   BRAIN

Dual-phase [18F]florbetapir in frontotemporal dementia

(2018) Michael Asghar et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Parametric methods for [18F]flortaucipir PET

(2018) Sandeep SV Golla et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Elevated 18 F-AV-1451 PET tracer uptake detected in incidental imaging findings

(2017) Samuel N. Lockhart et al.   NEUROLOGY

Frontotemporal dementia with the V337M MAPT mutation

(2017) Salvatore Spina et al.   NEUROLOGY

Metabolic topography of autoimmune non-paraneoplastic encephalitis

(2017) Madhavi Tripathi et al.   NEURORADIOLOGY

18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers

(2016) Ruben Smith et al.   BRAIN

Positron emission tomography imaging of tau pathology in progressive supranuclear palsy

(2016) Sarah Coakeley et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

[18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy

(2016) Jennifer L. Whitwell et al.   MOVEMENT DISORDERS

Subcortical18F-AV-1451 binding patterns in progressive supranuclear palsy

(2016) Hanna Cho et al.   MOVEMENT DISORDERS

Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy

(2016) Ruben Smith et al.   MOVEMENT DISORDERS

Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy

(2016) Jochen Hammes et al.   MOVEMENT DISORDERS

Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study

(2016) Elise G.P. Dopper et al.   NeuroImage-Clinical

[18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation

(2016) W. Richard Bevan Jones et al.   Annals of Clinical and Translational Neurology

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Invited review: Frontotemporal dementia caused bymicrotubule-associated protein taugene (MAPT) mutations: a chameleon for neuropathology and neuroimaging

(2015) Bernardino Ghetti et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia

(2014) E. G. P. Dopper et al.   NEUROLOGY

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Brain perfusion patterns in familial frontotemporal lobar degeneration

(2011) H. Seelaar et al.   NEUROLOGY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY